RxDoctor Payments Data

Natalia Sanchez

Physician Assistant · Bakersfield, CANPI 1164779534

Payments from drug & device makers

$2,389in general payments, 2019–2025

Across 95 payments — averaging $25.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$451
  • Boehringer Ingelheim$302
  • AbbVie$210
  • Lilly USA, LLC$195
  • Ardelyx, Inc.$194
  • Amgen$165
  • plus $871 from 13 others

What the payments were for

  • Food & beverage$2,389100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,389 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin103$97,937
OzempicSemaglutide54$48,014
JanuviaSitagliptin Phosphate33$33,908
LinzessLinaclotide35$25,467
RybelsusSemaglutide27$24,130
VascepaIcosapent Ethyl40$22,836
Metformin Er GastricMetformin Hcl12$14,657
JanumetSitagliptin Phos/Metformin Hcl17$13,295
TradjentaLinagliptin16$10,912
FarxigaDapagliflozin Propanediol14$8,841
Icosapent Ethyl40$7,118
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,056
MyrbetriqMirabegron15$6,645
Tresiba Flextouch U-100Insulin Degludec12$5,497
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$3,959

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$302$108,849119 claims
Novo NordiskOzempic, Rybelsus$451$72,14381 claims
MerckJanuvia, Janumet$79$47,20350 claims
AbbVieLinzess$210$25,46735 claims
AstraZenecaFarxiga$47$8,84114 claims
GSKTrelegy Ellipta$22$7,05612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Bakersfield

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →